Drug recall

Whole Blood, Leukocytes Reduced

FDA recall event 91733 · Class II · Vitalant

Key facts

Event ID 91733
Recall numbers B-0237-2023
Recalling firm Vitalant
Product type Biologics
Products Whole Blood, Leukocytes Reduced
Classification Class II
Status Terminated
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall Leukoreduced Whole Blood, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.
Initiation date Dec 6, 2022
Report date Mar 8, 2023
Termination date Mar 1, 2023
City Fargo
State ND
Country United States
FEI number 1771452

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls